Allogeneic BMT vs. chemotherapy in late bone marrow relapsed childhood non-T/non-B ALL: Results of BFM ALL relapse studies

Bone Marrow Transplantation

Volumn 18, Issue SUPPL. 2, 1996, Pages 28-30

  Schmid, H ^a   V Schenck, U ^a   Hartmann, R ^a   Borgmann, A ^a   Henze, G ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; BLAST CELL; CANCER RADIOTHERAPY; CHILD; CONFERENCE PAPER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; RECURRENCE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0029828856     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)

1. Dopfer R, Henze G, Bender-Götze C, Ebell W, Ehninger G, Friedrich W, Gadner H, Klingebiel T, Peters C, Riehm H, Suttorp M, Schmid H, Schmitz N, Siegert W, Stollmann-Gibbels B, Hartmann R, Niethammer D: Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German cooperative study. Blood 78:2780, 1991
2. Schmid H, Linderkamp C, Hartmann R, Fengler R, Henze G: Allogeneic BMT is superior to chemotherapy in early relapsed childhood ALL: results of four consecutive ALL-REZ BFM studies (abstr). Med Pediatr Oncol 23:203, 1994
3. Hammond D, Sather H, Nesbit M, Miller D, Coccia P, Bleyer A, Lukens J, Siegel S: Analysis of prognostic factors in acute lymphoblastic leukemia. Med Pediatr Oncol 14:124, 1986
4. Armitage JO: Bone marrow transplantation. N Engl J Med 330:827, 1994
5. Bührer C, Hartmann R, Fengler R, Dopfer R, Gadner H, Gerein V, Göbel U, Reiter A, Ritter J, Henze G: Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia. Med Pediatr Oncol 21:470, 1993
6. Bührer C, Hartmann R, Fengler R, Rath B, Schrappe M, Janka-Schaub G, Henze G: Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. J Clin Oncol. 1996 (in press)